1-9 of 9
Kai Xue
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Study of Chidamide Plus R-GDP Salvage Chemotherapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Ineligible for Autologous Transplantation: Efficacy and Safety Analysis

Guangliang Chen, Kai Xue, Qunling Zhang, Jia Jin, Yizhen Liu, Zuguang Xia, Fangfang Lyu, Xiaonan Hong, Xiaoqiu LI, Junning Cao
Journal: Blood
Blood (2023) 142 (Supplement 1): 5805.
https://doi.org/10.1182/blood-2023-174307
Published: 2023
Journal Articles

The non-cell-autonomous function of ID1 promotes AML progression via ANGPTL7 from the microenvironment

Ming-Yue Fei, Yong Wang, Bin-He Chang, Kai Xue, Fangyi Dong, Dan Huang, Xi-Ya Li, Zi-Juan Li, Cheng-Long Hu, Ping Liu, Ji-Chuan Wu, Peng-Cheng Yu, Ming-Hua Hong, Shu-Bei Chen, Chun-Hui Xu, Bing-Yi Chen, Yi-Lun Jiang, Na Liu, Chong Zhao, Jia-Cheng Jin, Dan Hou, Xin-Chi Chen, Yi-Yi Ren, Chu-Han Deng, Jia-Ying Zhang, Li-juan Zong, Rou-Jia Wang, Fei-Fei Gao, Hui Liu, Qun-Ling Zhang, Ling-Yun Wu, Jinsong Yan, Shuhong Shen, Chun-Kang Chang, Xiao-Jian Sun, Lan Wang
Journal: Blood
Blood (2023) 142 (10): 903–917.
https://doi.org/10.1182/blood.2022019537
Published: 2023
Includes: Supplemental data
Journal Articles

Deubiquitinase OTUD7B Is Potential Prognostic Biomarker in Diffuse Large B-Cell Lymphoma

Qunling Zhang, MD PhD, Juan Gu, MD PhD, Kai Xue, MD, Zuguang Xia, Cory Mavis, BSc, MSc, Francisco J. Hernandez-Ilizaliturri, MD, Ye Guo, Xiaonan Hong, Junning Cao, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4239.
https://doi.org/10.1182/blood-2018-99-118872
Published: 2018
Journal Articles

Protein Kinase C Delta in Diffuse Large B-Cell Lymphoma Post-Rituximab Era: Potential Prognostic Marker in Germinal Center B-Cell Lymphoma

Qunling Zhang, MD PhD, Juan Gu, MD PhD, Kai Xue, MD, Cory Mavis, BSc, MSc, Francisco J. Hernandez-Ilizaliturri, MD, Junning Cao, Xiaonan Hong, Ye Guo
Journal: Blood
Blood (2017) 130 (Supplement 1): 2839.
https://doi.org/10.1182/blood.V130.Suppl_1.2839.2839
Published: 2017
Journal Articles

Elevated High Sensitivity Troponin T (HsTnT) during Front-Line Therapy with Cyclophosphamide, Doxorubicin, Vincristine and Prednisone +/- Rituximab (CHOP+/-R) or Cyclophosphamide, Epirubicin, Vincristine and Prednisone +/- Rituximab (CEpOP+/-R) Correlates with a Decline in Left Ventricular Ejection Fraction (LVEF) in Patients with Aggressive B-Cell Lymphoma: Results from a Randomized Prospective Clinical Trial NCT00854568

Kai Xue, MD, Juan J Gu, PhD, Qunling Zhang, MD, Xiaojian Liu, MD, Jiachen Wang, Jianfeng Luo, Francisco J. Hernandez-Ilizaliturri, MD, Stanley F. Fernandez, MD, Myron S. Czuczman, MD, Junning Cao, MD Associate Professor, Xiaonan Hong, MD, Ye Guo, MD
Journal: Blood
Blood (2014) 124 (21): 3041.
https://doi.org/10.1182/blood.V124.21.3041.3041
Published: 2014
Journal Articles

Up-Regulation of Hexokinase II (HK) Alters the Glucose Metabolism and Disrupts the Mitochondrial Potential in Aggressive B-Cell Lymphoma Contributing to Rituximab-Chemotherapy Resistance and Is a Clinically Relevant Target for Future Therapeutic Development

Juan J Gu, PhD, Anil Singh, MD, Cory Mavis, MSc, Vivek Yanamadala, Kai Xue, MD, Michael Grau, Peter Lenz, Georg Lenz, Myron S. Czuczman, MD, Francisco Hernandez, MD
Journal: Blood
Blood (2014) 124 (21): 1767.
https://doi.org/10.1182/blood.V124.21.1767.1767
Published: 2014
Journal Articles

Vorinostat, a Histone Deacetylase (HDAC) Inhibitor, Is Active in Chemotherapy Resistant B-Cell Non-Hodgkin Lymphoma and Enhances the Anti-Tumor Activity of Chemotherapy Agents

Kai Xue, MD, Juan Gu, PhD, Cory Mavis, MSc, Francisco Hernandez, MD, Myron S. Czuczman, MD, Ye Guo, MD
Journal: Blood
Blood (2014) 124 (21): 5486.
https://doi.org/10.1182/blood.V124.21.5486.5486
Published: 2014
Journal Articles

Epirubincin Does Not Lower The Risk Of Cardiac Toxicity Than Doxorubicin In Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma Grade 3 (FLG3): Results From a 398-Case Prospective Randomized Phase III Clinical Trial (NCT00854568)

Kai Xue, MD, Zhang Qunling, MD, Xiaojian Liu, MD, Junning Cao, MD, Xiaonan Hong, MD, Ye Guo, MD
Journal: Blood
Blood (2013) 122 (21): 372.
https://doi.org/10.1182/blood.V122.21.372.372
Published: 2013
Journal Articles

L-Asparaginase Monotherapy in Patients with Relapsed or Refractory Extranodal NK/T-Cell Lymphoma, Nasal Type: Results of A Phase II Study.

Ye Guo, Xuejun Ma, Zuguang Xia, Kai Xue, Qunling Zhang, Xiaonan Hong
Journal: Blood
Blood (2012) 120 (21): 2730.
https://doi.org/10.1182/blood.V120.21.2730.2730
Published: 2012